Strain clinical evidence mixedProbiotic
A rare consumer probiotic with a clearly identified strain (Bifidobacterium 35624) linked to randomized evidence, including a positive IBS trial and a separate neutral symptom-severity trial in a non-patient population.
Relevant for: People comparing probiotics by exact strain rather than CFU marketingTradeoff: Far better strain transparency than generic blends, but benefits are indication-, population- and dose-specific.
Desk researchedFoot care
A fragrance-free foot cream with a manufacturer-stated 15% lactic-acid AHA system and a formula that also lists glycerin, mineral oil and petrolatum.
- Urea
- Not listed / not established
- Vehicle
- Cream
Relevant for: lactic-acid foot-cream comparisonsTradeoff: The 15% AHA concentration is unusually clear for comparison, but the label carries the expected irritation and sun-sensitivity cautions for an alpha-hydroxy-acid product.
Desk researchedFoot care
An OTC skin-protectant ointment with 41% petrolatum plus panthenol, glycerin, mineral oil, ceresin, bisabolol and lanolin alcohol; no keratolytic acid or urea is listed in the cited formula.
- Urea
- Not listed / not established
- Vehicle
- OTC skin-protectant ointment
Relevant for: occlusive barrier comparisonsTradeoff: This is primarily an occlusive skin-protectant profile, so it is not directly equivalent to high-urea or acid-based rough-skin products.
Desk researchedAntifungal care
A loose topical powder with miconazole nitrate 2% labeled for most athlete's foot, jock itch and ringworm.
- Active
- Miconazole nitrate · 2%
- Vehicle
- Loose topical powder
Relevant for: comparing non-aerosol powder with cream, liquid spray and powder spray vehiclesTradeoff: The loose-powder vehicle avoids aerosol handling warnings but uses the longer miconazole-labeled treatment courses and requires powder application.
Desk researchedEssential oil
A widely available Lavandula angustifolia bottle with an external-use label and a linked GC/MS document; its practical edge is transparent identity rather than any claim that lavender aromatherapy is a proven treatment.
Relevant for: buyers who want a 0.5 fl oz retail bottle with GC/MS documentationTradeoff: Easy-to-understand bottle data, but the brand’s benefit language should not be confused with evidence certainty.
Desk researchedAir purifier
A mechanically filtered purifier emphasizing a large activated-carbon/mineral bed plus HEPA media, with the manufacturer stating that it does not intentionally generate ozone or ions.
Relevant for: See fact sheetTradeoff: It is physically heavy and the cited manufacturer page does not publish the same CADR/ACH, power or acoustic fields that some competitors provide.
Desk researchedEczema care
Baby-positioned balm with colloidal oatmeal, ceramide NP and oat oil; current package directions remain important for pediatric use.
- Active
- Colloidal oatmeal
- Vehicle
- Balm
Relevant for: baby balm vehicle comparisonsTradeoff: The formula is well described, while individual pediatric suitability is not established by the product page.
Desk researchedEczema care
Daily eczema cream with colloidal oatmeal and ceramide; the surfaced primary page does not publish an oatmeal percentage, so none is inferred.
- Active
- Colloidal oatmeal
- Vehicle
- Cream
Relevant for: daily cream vehicle comparisonsTradeoff: The active ingredient is clear; its concentration is intentionally recorded as not established from the surfaced page.
Desk researchedEczema care
Rich nighttime balm with colloidal oatmeal and ceramide; concentration is not inferred where the surfaced page does not state it.
- Active
- Colloidal oatmeal
- Vehicle
- Balm
Relevant for: balm versus cream comparisonsTradeoff: Vehicle richness is visible; comparative effectiveness is not established.
Desk researchedEczema care
Gel-cream with 2% colloidal oatmeal and shea butter, with fragrance- and steroid-free labeling.
- Active
- Colloidal oatmeal · 2%
- Vehicle
- Gel cream
Relevant for: comparing higher-published oatmeal concentrationsTradeoff: A higher labeled percentage is a formulation fact, not a head-to-head efficacy result.
Manufacturer documentedFoot care
A USDA Certified Organic oil-and-beeswax balm with no urea or exfoliating acid, plus multiple aromatic essential oils.
- Urea
- Not listed / not established
- Vehicle
- Balm in tin
Relevant for: dry intact heels where an oil-and-wax occlusive balm is preferredTradeoff: Simple organic occlusive formula and recyclable tin, but no keratolytic active and a substantial essential-oil profile.
Evidence mappedPrebiotic
Bimuno is a rare retail prebiotic where the branded substrate, B-GOS, has placebo-controlled human symptom data. A crossover trial used 2.75 g/day B-GOS and reduced bloating, flatulence and abdominal pain over two weeks, while bowel frequency, stool consistency and quality of life did not improve. Current retail labeling reports a 3.65 g sachet containing about 2.9 g GOS.
Relevant for: People who specifically want a galactooligosaccharide with human B-GOS trial dataTradeoff: Unusually good ingredient-to-study match; milk-derived GOS and fermentability are meaningful tolerability constraints.
Evidence mappedProbiotic
Bio-K+ discloses three proprietary strains and guarantees 50 billion CFU through expiration. Two of those strains—L. acidophilus CL1285 and L. casei LBC80R—appear together in AGA guidance for C. difficile prevention during antibiotic treatment. However, a later large hospital cluster-randomized trial of the three-strain Bio-K+ capsule did not significantly reduce hospital-acquired C. difficile infection.
Relevant for: People comparing probiotics with named strains and a direct professional-guideline connectionTradeoff: The product names its strains and guarantees CFU through expiration. Two strains appear in AGA guidance, while a later cluster-randomized hospital trial of the three-strain capsule did not significantly reduce hospital-acquired C. difficile infection.
Desk researchedAir purifier
A high-CADR room purifier using Blueair's HEPASilent combination of mechanical and electrostatic filtration, with current room-size and CADR figures published under updated U.S. DOE presentation.
Relevant for: See fact sheetTradeoff: Blueair notes that CADR and room-size values have been updated to newer DOE standards, so current web values should not be silently mixed with older packaging or archived figures.
Manufacturer documentedRed light device
A larger two-wavelength mains-powered BON CHARGE panel with manufacturer-published dimensions, LED count and power, plus a current manual index; independent output measurements are not normalized in the current record.
Relevant for: larger two-wavelength manufacturer-spec comparisonsTradeoff: Primary product documentation is detailed enough for physical and electrical facts, but optical-output comparability remains limited by missing independent method detail.
Manufacturer documentedRed light device
A rechargeable two-wavelength handheld device with primary manufacturer specifications and a current manual index, but no normalized independent radiometric report in the Homeapotherapy record.
Relevant for: portable targeted-use specification comparisonsTradeoff: The compact battery format is well documented by the manufacturer, while its published irradiance cannot be normalized against calibrated third-party panel measurements without method details.
Manufacturer documentedFoot care
An emollient-focused overnight foot cream centered on coconut oil and botanical/aromatic ingredients rather than urea or exfoliating acids.
- Urea
- Not listed / not established
- Vehicle
- Cream
Relevant for: overnight emollient care for dry intact feetTradeoff: Rich overnight emollient profile, but not a substitute for a documented high-urea or acid formula when thick hyperkeratotic skin is the main problem.
Product trial mixed resultsMultivitamin
COSMOS provides product-specific randomized evidence for this OTC multivitamin: the trials found modest cognition and memory benefits in older adults, while a separate COSMOS-Mind analysis did not significantly reduce new MCI or dementia over three years.
Relevant for: Older adults comparing products on actual randomized product evidenceTradeoff: Much stronger clinical evidence than most multivitamins, but weaker sourcing/organic credentials and important negative endpoints prevent a simplistic 'proven' label.
Desk researchedEczema care
Baby-positioned cream with 1% colloidal oatmeal, ceramides and fragrance-free labeling; pediatric package directions remain controlling.
- Active
- Colloidal oatmeal · 1%
- Vehicle
- Cream
Relevant for: comparing baby-positioned colloidal-oatmeal creamsTradeoff: Baby branding does not replace age-specific label review.
Desk researchedEczema care
Creamy-oil vehicle with 1% colloidal oatmeal plus ceramides and humectants; useful as a vehicle-versus-active comparison record.
- Active
- Colloidal oatmeal · 1%
- Vehicle
- Creamy oil
Relevant for: comparing cream versus oil-like vehiclesTradeoff: Ingredient richness is a formula fact, not evidence that it will outperform a simpler cream.
Desk researchedEczema care
Cream with 1% colloidal oatmeal, three ceramides and a fragrance-free formula; normalized as an OTC skin-protectant record, not a ranking.
- Active
- Colloidal oatmeal · 1%
- Vehicle
- Cream
Relevant for: comparing colloidal-oatmeal creamsTradeoff: The primary source establishes formulation and label facts, not superiority.
Manufacturer documentedFoot care
A fragrance-free, lanolin-free skin-protectant ointment with 46.5% petrolatum plus ceramides and hyaluronic acid; it fits barrier protection rather than callus exfoliation.
- Urea
- Not listed / not established
- Vehicle
- Ointment
Relevant for: very dry or cracked intact heel skin where occlusion and barrier support are the main jobTradeoff: Strongly documented barrier formula with a precise petrolatum percentage and no fragrance/lanolin, but no keratolytic active for thick callus.
Desk researchedEczema care
OTC anti-itch cream with 1% pramoxine hydrochloride, three ceramides and no steroid; kept separate from daily barrier moisturizers.
- Active
- Pramoxine hydrochloride · 1%
- Vehicle
- Cream
Relevant for: comparing OTC anti-itch activesTradeoff: The OTC active changes the product job; it should not be compared as if it were only a barrier cream.
Desk researchedPsoriasis care
Leave-on cream with 2% salicylic acid plus urea, lactic acid, ceramides and moisturizers; normalized as a psoriasis OTC treatment record, not a ranking.
Relevant for: comparing salicylic-acid cream vehiclesTradeoff: The formula combines scale-directed treatment and moisturization, but ingredient richness does not establish comparative superiority.
Desk researchedEczema care
Lightweight gel with 0.5% colloidal oatmeal, fragrance-/steroid-/paraben-free labeling and a distinct vehicle from the line's creams.
- Active
- Colloidal oatmeal · 0.5%
- Vehicle
- Gel
Relevant for: gel versus lotion/cream comparisonsTradeoff: Concentration and vehicle are explicit; outcome ranking is not.
Desk researchedEczema care
2% colloidal-oatmeal cream with glycerin, shea butter, sunflower oil, dimethicone and ceramide NP; steroid- and fragrance-free.
- Active
- Colloidal oatmeal · 2%
- Vehicle
- Cream
Relevant for: 2% oatmeal cream comparisonsTradeoff: A higher labeled active percentage is not itself a head-to-head outcome.
Desk researchedEczema care
1% colloidal-oatmeal lotion positioned for eczema-prone skin maintenance; kept distinct from the brand's 2% rapid-relief cream and 0.5% gel.
- Active
- Colloidal oatmeal · 1%
- Vehicle
- Lotion
Relevant for: lotion versus cream comparisonsTradeoff: Vehicle and concentration differ within the same line, while superiority is not established.
Desk researchedAntifungal care
Prescription 10 mg clotrimazole lozenge designed for topical oral administration and used in mild oropharyngeal candidiasis pathways.
- Active
- Clotrimazole
- Vehicle
- Troche / slowly dissolving oral lozenge
Relevant for: oral-thrush local-treatment comparisonsTradeoff: Local oral exposure requires repeated slowly dissolved doses.
Desk researchedPsoriasis care
OTC anti-itch lotion with 1% hydrocortisone; its drug role differs from salicylic-acid scale softeners and plain moisturizers.
Relevant for: comparing OTC hydrocortisone label limitsTradeoff: Hydrocortisone targets itch/inflammatory symptoms, while psoriasis control may require a broader condition-specific plan.
Desk researchedAir purifier
A conventional filtered room purifier with explicit CADR figures and room coverage stated at multiple air-changes-per-hour levels.
Relevant for: See fact sheetTradeoff: Its standardized clean-air metrics are useful for ventilation-style comparison, but they are not the same type of claim as Vollara's ActivePure diffusion coverage figures.
Strain clinical evidence with negative useProbiotic
Contains the extensively studied LGG strain and guarantees viable count through expiration, but one randomized hospital trial found LGG did not prevent acquisition of antimicrobial-resistant organisms; evidence for one use must not be recycled into another.
Relevant for: People who want a named probiotic strain and expiration-date CFU guaranteeTradeoff: Strong strain identity and viability documentation, but no probiotic strain is universally effective across conditions.
Manufacturer documentedFoot care
A petrolatum-free-on-cited-label oil/wax barrier ointment with shea butter, paraffin and ceramide NP, explicitly positioned for extra-dry areas including heels and feet.
- Urea
- Not listed / not established
- Vehicle
- Ointment
Relevant for: very dry intact heels where an oil/wax/ceramide ointment is preferredTradeoff: Adds a meaningfully different petrolatum-free barrier vehicle, but offers no disclosed keratolytic strength for thick callus.
Evidence mappedPrebiotic
The NIH label record lists 5 g larch extract yielding 4.25 g arabinogalactans per scoop. The strongest modern microbiome RCT cited here used 15 g/day of the branded ResistAid ingredient rather than this DaVinci finished product.
Relevant for: Adults comparing a gram-dose larch arabinogalactan powder rather than a small immune-support capsuleTradeoff: The label states the arabinogalactan amount clearly, but published ResistAid trials are not exact DaVinci finished-product trials.
Manufacturer documented with discrepancyFoot care
A fragrance-free heel cream marketed with 25% urea and 6% alpha hydroxy acids, with a primary-page copy inconsistency that should be checked against the current package before strength-sensitive purchasing.
- Urea
- 25% in product title/description; page also contains an isolated conflicting 10% sentence
- Vehicle
- Cream
Relevant for: intact thick, callused heel skin where a combined urea+AHA system is desiredTradeoff: One of the strongest documented combined urea/AHA profiles in the catalog, but the manufacturer page itself contains a concentration discrepancy that reduces confidence until package verification.
Desk researchedPsoriasis care
Rinse-off scalp treatment with 3% salicylic acid; Drug Facts cover scalp symptoms from psoriasis and seborrheic dermatitis and specify contact time.
Relevant for: comparing scalp-specific salicylic-acid vehiclesTradeoff: The 3% active concentration is meaningful only with the shampoo vehicle, scalp location and directed several-minute contact time.
Manufacturer documentedFoot care
A dedicated dry/cracked-foot cream with a manufacturer-stated 25% urea concentration plus lactic and malic acids, lanolin and aromatic essential oils.
- Urea
- 25%
- Vehicle
- Cream
Relevant for: intact thick dry heel skin where a published high urea concentration mattersTradeoff: The 25% urea concentration is unusually clear, but the fragranced formula includes lanolin and multiple essential oils.
Manufacturer documentedFoot care
A foot lotion with a manufacturer-stated 10% alpha-hydroxy-acid complex, plus urea, glycerin and multiple aromatic oils. It is more explicitly exfoliation-focused than a basic moisturizer.
- Urea
- Present; concentration not stated
- Vehicle
- Lotion
Relevant for: rough, flaky intact foot skinTradeoff: The AHA percentage is explicit for comparison, while the urea percentage is not and the formula is fragranced.
Manufacturer documentedFoot care
A heel-targeted balm with a manufacturer-stated 25% urea concentration plus glycerin, shea butter, cocoa butter and aromatic essential oils.
- Urea
- 25%
- Vehicle
- Balm
Relevant for: intact thick or very dry heel skin where a published 25% urea strength is usefulTradeoff: The urea strength is explicit and heel-specific, but peppermint and lavender oils make it a poor fit for fragrance-sensitive skin.
Manufacturer documentedFoot care
A high-strength keratolytic cream with manufacturer-stated 40% urea and 2% salicylic acid, intended for thick, rough, callused intact skin rather than open fissures.
- Urea
- 40%
- Vehicle
- Cream
Relevant for: thick intact heel callus where a high-strength dual keratolytic is being comparedTradeoff: Provides unusually explicit high-strength percentages, but the stronger keratolytic profile and tea tree oil increase the importance of tolerability and correct use.
Desk researchedWater ionizer
An eight-plate countertop ionizer with manufacturer-published pH, ORP, flow and electrical specifications plus a filter-change monitoring feature.
Relevant for: See fact sheetTradeoff: Enagic's pH and ORP figures are manufacturer specifications; this record does not treat them as clinical efficacy outcomes.
Desk researchedAntifungal care
A single-dose tioconazole 6.5% vaginal ointment labeled for vaginal yeast infection in people age 12 and older who match the diagnostic guardrails on the Drug Facts label.
- Active
- Tioconazole · 6.5% (300 mg per applicator)
- Vehicle
- Vaginal ointment in prefilled applicator
Relevant for: comparing single-dose vaginal azole regimensTradeoff: One-dose describes the administration schedule, not guaranteed symptom resolution in one day; the label says complete relief can take up to 7 days.
Manufacturer documentedFoot care
A fragrance-free repair cream that Eucerin includes in hand/foot care, with 5% urea at the line level, ceramide-3, natural moisturizing factors and an AHA-related sun-sensitivity warning.
- Urea
- 5% stated for Advanced Repair line
- Vehicle
- Cream
Relevant for: daily dry-foot maintenance where fragrance-free barrier support mattersTradeoff: Fragrance-free and barrier-oriented with a lower urea level, but less targeted to thick callus than high-urea heel formulas.
Desk researchedEczema care
Baby-positioned 1% colloidal-oatmeal cream with ceramide-3 and licorice-root extract; labeled for 3 months and older.
- Active
- Colloidal oatmeal · 1%
- Vehicle
- Cream
Relevant for: baby cream age-label comparisonsTradeoff: The label is specific on age and active concentration; individual tolerability remains personal.
Desk researchedEczema care
Non-foaming baby wash with 2% colloidal oatmeal and a mild surfactant system; kept separate from leave-on creams.
- Active
- Colloidal oatmeal · 2%
- Vehicle
- Cream wash
Relevant for: wash versus leave-on product comparisonsTradeoff: The 2% active is explicit, but vehicle/contact time differs from a leave-on cream.
Desk researchedEczema care
1% colloidal-oatmeal skin-protectant cream for adults, children and babies 3 months and older per current manufacturer labeling.
- Active
- Colloidal oatmeal · 1%
- Vehicle
- Cream
Relevant for: age-label comparisonsTradeoff: Age wording is unusually explicit, but it still does not establish superiority.
Desk researchedEczema care
Lightweight hydrogel with colloidal oatmeal and glycerin, fragrance- and steroid-free, labeled for ages 3 months and older.
- Active
- Colloidal oatmeal
- Vehicle
- Hydrogel
Relevant for: hydrogel versus cream comparisonsTradeoff: The page clearly describes vehicle and age scope but does not surface an oatmeal percentage.
Desk researchedFoot care
A fragrance-free rough-skin cream with manufacturer-stated 10% urea, AHA and Ceramide-3. It is positioned for rough, bumpy skin rather than exclusively as a heel product.
- Urea
- 10%
- Vehicle
- Cream
Relevant for: 10% urea cream comparisonsTradeoff: It combines moderate urea with AHA and a ceramide in a fragrance-free cream, but it is a broader rough-skin product rather than a dedicated fissure treatment.
Desk researchedFoot care
A fragrance-free lotion with manufacturer-stated 10% urea, AHA and Ceramide-3, useful as a lower-viscosity comparison against dedicated heel creams and balms.
- Urea
- 10%
- Vehicle
- Lotion
Relevant for: 10% urea lotion comparisonsTradeoff: The lotion format may spread more easily over larger areas, while a dedicated heel balm may provide a thicker application for localized fissure-prone skin.
Desk researchedFoot care
A heel balm with a manufacturer-stated 25% urea concentration plus glycolic acid, lanolin, mineral oil, paraffin, shea butter and other emollient ingredients.
- Urea
- 25%
- Vehicle
- Balm
Relevant for: high-urea heel-balm comparisonsTradeoff: The urea percentage is explicit and useful for comparison, while the longer fragranced formula contains several ingredients some users may prefer to avoid.
Manufacturer documentedFoot care
A mess-reducing heel stick with 9% urea plus petrolatum, shea butter, lanolin oil, beeswax and plant oils; a lower-urea maintenance-format contrast to Flexitol's 25% Heel Balm.
- Urea
- 9%
- Vehicle
- Solid heel stick
Relevant for: dry intact heels where a stick format is easier to applyTradeoff: Convenient stick application and a published 9% urea level, but includes lanolin oil and parfum and is less keratolytic than high-urea creams.
Evidence mappedSynbiotic
A transparent synbiotic built around the same disclosed S. boulardii CNCM I-745 strain as Florastor Dual Action, plus 600 mg chicory-root inulin per two-capsule serving. The probiotic identity is strong; the small inulin dose should not be mistaken for proof of a clinically meaningful prebiotic effect in the finished product.
Relevant for: People comparing a strain-identified yeast probiotic that also contains a small amount of prebiotic fiberTradeoff: Very good ingredient transparency, but the finished synbiotic has a weaker evidence bridge than the underlying CNCM I-745 strain.
Evidence mappedProbiotic
Florastor discloses Saccharomyces boulardii CNCM I-745. AGA guidance includes S. boulardii as one option during antibiotic use when the goal is C. difficile prevention, but that guidance is not a Florastor brand endorsement.
Relevant for: Adults comparing a clearly identified S. boulardii strainTradeoff: The strain is disclosed and the product is stored at room temperature; usefulness remains indication-specific, and serious-infection risk matters in vulnerable patients.
Desk researchedAntifungal care
Prescription systemic azole used across several candidiasis indications; regimen and safety considerations vary substantially by body site.
- Active
- Fluconazole
- Vehicle
- Oral tablet
Relevant for: understanding systemic candidiasis treatment pathwaysTradeoff: Systemic reach versus broader interaction, hepatic, QT and pregnancy considerations.
Organic quality documentedMultivitamin
A well-documented organic children’s formula, but AAP guidance says most healthy children eating a varied diet do not need a routine multivitamin; the first decision is whether supplementation is indicated at all.
Relevant for: Families with a pediatrician-identified need who specifically want an organic powderTradeoff: Strong certification profile does not overcome the fact that many healthy children simply do not need a multivitamin.
Organic quality documentedMultivitamin
A certified-organic, Non-GMO and vegan men’s multivitamin built around 30+ organic food ingredients; the certification story is stronger than the product-specific clinical-efficacy record.
Relevant for: Men prioritizing USDA Organic certificationTradeoff: High organic-certification value, but no qualifying product-specific randomized clinical-outcome trial found.
Organic quality documentedMultivitamin
The formula is USDA Organic, Non-GMO Project Verified and Certified Vegan. Those certifications describe sourcing and production attributes; they do not establish that the exact product improves clinical outcomes.
Relevant for: Adults seeking a certified-organic women’s multivitaminTradeoff: USDA Organic certification and once-daily dosing are clear label features; no qualifying product-specific efficacy trial was identified.
Manufacturer documentedFoot care
A foot-specific rich salve centered on lanolin and petrolatum with panthenol, bisabolol, zinc oxide, camphor and aromatic oils, positioned for very cracked, dry and rough skin.
- Urea
- Not listed / not established
- Vehicle
- Salve / ointment
Relevant for: very dry or cracked heel skin where a rich foot-specific salve is preferredTradeoff: Purpose-built for cracked foot skin with a rich occlusive profile, but lanolin, camphor and multiple aromatic oils narrow its fit for sensitive users.
Manufacturer documentedFoot care
A foot-specific OTC skin-protectant cream with 30% white petrolatum and 3% dimethicone, fragrance-free and formulated without lanolin or oils.
- Urea
- Not listed / not established
- Vehicle
- Cream
Relevant for: very dry or cracked intact feet where exact barrier-active percentages are usefulTradeoff: Exceptionally clear OTC barrier percentages and sensitivity profile, but it is a protectant/moisturizer rather than a strong keratolytic.
Desk researchedEczema care
Hand-focused 2% colloidal-oatmeal cream with petrolatum and ceramide NG; fragrance-, steroid- and dye-free.
- Active
- Colloidal oatmeal · 2%
- Vehicle
- Hand cream
Relevant for: hand-specific vehicle/packaging comparisonsTradeoff: The hand-focused format is a use-context difference, not proof of better eczema control.
Desk researchedEczema care
2% colloidal-oatmeal cream with glycerin, dimethicone, petrolatum, shea butter and ceramide NG; fragrance-, steroid- and dye-free.
- Active
- Colloidal oatmeal · 2%
- Vehicle
- Cream
Relevant for: 2% oatmeal cream comparisonsTradeoff: The formulation is detailed, but comparative superiority is not established.
Manufacturer documentedFoot care
A dedicated daily foot moisturizer positioned for dry, rough heels. It belongs in the hydration/maintenance group rather than being treated as a high-strength keratolytic unless a current label states otherwise.
- Urea
- Not listed / not established
- Vehicle
- Cream
Relevant for: routine dry-foot moisturizationTradeoff: Straightforward daily-foot positioning, but less useful for strength comparison than formulas with explicit active percentages.
Desk researchedPsoriasis care
Leave-on cream with 3% salicylic acid plus petrolatum, glycerin, dimethicone and ceramides; Drug Facts cover psoriasis and seborrheic dermatitis.
Relevant for: comparing 3% salicylic-acid cream recordsTradeoff: A higher published salicylic-acid percentage is a label fact, not evidence of better outcomes for every person or body site.
Manufacturer documentedFoot care
A fragranced daily foot cream whose published ingredient list includes urea, glycerin, petrolatum, dimethicone, lactic acid and shea-butter extract; concentrations are not stated.
- Urea
- Present; concentration not stated
- Vehicle
- Cream
Relevant for: daily rough-foot moisturization with both humectant and occlusive ingredientsTradeoff: Broad moisture and softening ingredient profile, but no published active concentration for strength-based comparison.
Desk researchedHydrogen water device
A 280 mL PEM/SPE hydrogen-water bottle with cycle, ORP, USB-C charging and one-year warranty information published by the manufacturer.
Relevant for: See fact sheetTradeoff: The current page contains internally inconsistent hydrogen-concentration and dimension statements, so Homeapotherapy preserves those conflicts instead of converting or selecting the most favorable number.
Desk researchedRed light device
A 300-LED two-wavelength PRO-series panel. The current manual lists 530 W electrical consumption, which should not be silently substituted with differently dated web-chart values.
Relevant for: larger two-wavelength panel comparisonsTradeoff: Primary documentation is available, but conflicting manufacturer web figures make source dates especially important.
Desk researchedRed light device
A compact two-wavelength panel with a 60-degree beam angle and 112 W manual-listed power consumption. Hooga separately publishes unusually explicit limits on finished-panel certification claims.
Relevant for: compact two-wavelength comparisonsTradeoff: The hardware is comparatively simple; the public manual is older, so current commercial terms should be checked against the live product page.
Desk researchedRed light device
A wide 900-LED two-wavelength PRO-series panel with a current manual listing 1200 W electrical consumption and a 61.2 × 15.7 inch face.
Relevant for: large-panel hardware comparisonsTradeoff: The hardware record is detailed, but manufacturer irradiance charts are not independent verification.
Desk researchedRed light device
A two-wavelength PRO-series panel with 150 dual-chip LEDs and a current primary manual that separates its 750 W lamp-power label from 272 W listed electrical consumption.
Relevant for: mid-size two-wavelength comparisonsTradeoff: The current manual is specific about hardware, but the irradiance charts remain manufacturer-generated.
Desk researchedRed light device
A taller 300-LED four-wavelength ULTRA panel with pulse controls and a 39.5-inch manual-listed height.
Relevant for: larger four-wavelength comparisonsTradeoff: The manual gives a broad hardware record; independent measurements remain the main evidence gap.
Desk researchedRed light device
A compact four-wavelength ULTRA-series panel with 72 LEDs, pulse controls and a 116.4 W manual-listed electrical output figure.
Relevant for: compact four-wavelength comparisonsTradeoff: The current manual is unusually information-dense, but its output and irradiance figures remain manufacturer documentation.
Desk researchedRed light device
A 150-LED four-wavelength ULTRA panel with adjustable pulse controls and a 20.4-inch manual-listed height.
Relevant for: mid-size four-wavelength comparisonsTradeoff: Detailed controls and hardware documentation, but no normalized independent optical test is in the record.
Desk researchedHydrogen water device
A portable PEM/SPE hydrogen-water bottle whose current marketing page publishes multiple concentration statements, including 1,600 ppb after 3 minutes and 3,000 ppb after 10 minutes.
Relevant for: See fact sheetTradeoff: The current manufacturer page contains concentration figures that are not internally consistent enough to collapse into one definitive number, and it does not publish several comparison fields such as ORP, dimensions, weight or a conventional warranty term.
Desk researchedAir purifier
A multi-stage filtered purifier with published six-speed airflow, power and sound data, a gas/odor stage, HyperHEPA particle filtration and current manufacturer coverage up to 1,125 square feet.
Relevant for: See fact sheetTradeoff: IQAir publishes detailed operating data, but its 1,125-square-foot maximum-coverage statement is not presented as an AHAM CADR room-size value and should not be normalized as one.
Manufacturer documentedRed light device
A modular Generation 3.0 Joovv panel using 660 nm red and 850 nm near-infrared light, with current setup documentation and explicit OTC Class II intended-use language for the Mini 3.0.
Relevant for: small-coverage modular panel comparisonsTradeoff: Joovv publishes unusually explicit intended-use and safety-certification language, but the current normalized record does not contain a directly comparable independent irradiance protocol.
Manufacturer documentedRed light device
A larger modular Generation 3.0 Joovv panel using 660 nm red and 850 nm near-infrared light, with Recovery+ and Ambient modes plus explicit OTC Class II intended-use language.
Relevant for: moderate-coverage modular panel comparisonsTradeoff: The product and safety documentation is strong on intended use, modes and system design, while normalized cross-brand optical-output comparability remains incomplete.
Desk researchedFoot care
A petrolatum-based foot ointment with urea and salicylic acid. The manufacturer publishes the full ingredient list but does not state the urea or salicylic-acid concentrations on the cited page.
- Urea
- Present; concentration not stated
- Vehicle
- Ointment
Relevant for: comparing a combined occlusive + keratolytic formulaTradeoff: The formula combines occlusion and exfoliating ingredients, but the cited primary page does not publish the urea or salicylic-acid percentages.
Desk researchedFoot care
A nighttime variant of Kerasal's petrolatum, urea and salicylic-acid ointment that adds lavender and chamomile oils. Published concentrations are not provided on the cited page.
- Urea
- Present; concentration not stated
- Vehicle
- Ointment
Relevant for: comparing scented nighttime heel ointmentsTradeoff: It keeps the same core exfoliating/occlusive profile while adding aromatic oils, which may be unwanted in a minimalist formula.
Evidence mappedPrebiotic
A practitioner-oriented 5 g proprietary prebiotic blend combining GOS with yeast-derived beta-1,3/1,6-glucan. The product is useful as a formulation comparator but weak for dose-to-trial matching because SFI does not disclose the individual GOS and beta-glucan amounts. Evidence for gram-dose GOS or oat beta-glucan cannot be assigned to the blend by ingredient name alone.
Relevant for: People already using Galactomune with a clinician who want its formulation limitations made explicitTradeoff: Convenient practitioner blend and clear total blend weight, but proprietary component quantities prevent rigorous trial-dose matching.
Desk researchedAntifungal care
A three-night miconazole regimen using 200 mg vaginal suppositories plus 2% external cream for associated vulvar itching and irritation.
- Active
- Miconazole nitrate · 200 mg per vaginal suppository + 2% external cream
- Vehicle
- Three vaginal suppositories + external cream
Relevant for: comparing 3-day miconazole with 1-dose and 7-day vaginal azole regimensTradeoff: This uses three nightly vaginal doses rather than one or seven; regimen length should not be treated as a simple potency ranking.
Desk researchedEczema care
Eczema cream with 1% colloidal oatmeal and steroid-/antibiotic-free positioning; normalized around label scope rather than brand claims.
- Active
- Colloidal oatmeal · 1%
- Vehicle
- Cream
Relevant for: 1% colloidal-oatmeal cream comparisonsTradeoff: The active and label scope are clear; marketing context does not establish head-to-head benefit.
Ingredient clinical evidence mixed product dataDigestive enzyme
Fast Act provides 9,000 FCC lactase units per caplet. Randomized evidence supports oral lactase for lactose intolerance, while older product-comparison evidence shows that lower breath hydrogen does not always correspond to significant symptom relief.
Relevant for: People with lactose intolerance who want a targeted enzyme for lactose-containing mealsTradeoff: Its single-enzyme, substrate-specific use is easier to map to clinical evidence than broad proprietary enzyme blends; symptom response still varies.
Desk researchedAntifungal care
A topical terbinafine hydrochloride 1% cream labeled for most athlete's foot, jock itch and ringworm. The label explicitly excludes nails, scalp and vaginal yeast infections.
- Active
- Terbinafine hydrochloride · 1%
- Vehicle
- Cream
Relevant for: comparing terbinafine 1% topical treatmentTradeoff: The labeled treatment duration varies by infection location, and the skin cream should not be generalized to nail or mucosal infections.
Evidence mappedPrebiotic
A single-HMO powder centered on 2'-fucosyllactose, with the manufacturer recommending 2 g as a starting serving. Human HMO trials show convincing microbiota effects, especially increased Bifidobacterium, but IBS symptom improvement and immune outcomes are much less certain than the product marketing implies.
Relevant for: Adults specifically interested in 2'-FL/HMO microbiota researchTradeoff: HMO biology and bifidogenic human data are compelling, but the retail starting dose is below many adult trials and several marketed clinical claims overreach the available endpoints.
Desk researchedAntifungal care
A talc-free miconazole nitrate 2% powder spray labeled for most athlete's foot and useful when a dry aerosol format is preferred over cream.
- Active
- Miconazole nitrate · 2%
- Vehicle
- Talc-free aerosol powder spray
Relevant for: comparing dry powder spray versus creamTradeoff: The aerosol format goes on dry but adds flammability and pressurized-container warnings that creams do not have.
Desk researchedAntifungal care
A clotrimazole 1% topical cream labeled for most athlete's foot, jock itch and ringworm, with condition-specific stop-and-seek-care timing in the Drug Facts label.
- Active
- Clotrimazole · 1%
- Vehicle
- Cream
Relevant for: comparing clotrimazole 1% creamsTradeoff: Its broad skin-fungus labeling is useful, but treatment courses are longer than some terbinafine or butenafine regimens and product labeling should control.
Desk researchedAntifungal care
A butenafine hydrochloride 1% cream whose current label is specific about athlete's foot between the toes and states that effectiveness on the bottom or sides of the foot is unknown.
- Active
- Butenafine hydrochloride · 1%
- Vehicle
- Cream
Relevant for: interdigital athlete's-foot comparisonsTradeoff: The label supports a relatively short interdigital athlete's-foot regimen but is unusually explicit about uncertainty for other foot locations.
Desk researchedPsoriasis care
Coal-tar ointment with a 2% coal tar active; its Drug Facts cover psoriasis, seborrheic dermatitis and dandruff symptom treatment.
Relevant for: comparing coal tar with salicylic-acid or hydrocortisone treatment rolesTradeoff: Coal tar is a distinct treatment class with vehicle and interaction considerations that are not captured by comparing percentage alone.
Desk researchedAntifungal care
A one-dose miconazole vaginal insert (1200 mg) paired with 2% external miconazole cream for associated vulvar itching and irritation.
- Active
- Miconazole nitrate · 1200 mg vaginal insert + 2% external cream
- Vehicle
- One-dose vaginal insert + external cream
Relevant for: comparing one-dose miconazole with 3-day and 7-day vaginal azole regimensTradeoff: The vaginal insert is one dose, but the label notes symptom relief can take several days and the external cream may be used twice daily for up to 7 days.
Independent lab documentedRed light device
A larger eight-wavelength, mode-selectable MitoADAPT panel with current manufacturer specifications and a completed LightLab report for the tested MAX 4.0 sample.
Relevant for: larger-panel comparisons with completed third-party radiometric measurementsTradeoff: The MAX 4.0 has unusually detailed third-party hardware measurements, but those measurements describe a submitted sample and protocol rather than clinical superiority.
Manufacturer documentedRed light device
A mid-size eight-wavelength, mode-selectable MitoADAPT panel with current manufacturer specifications; Mito's independent-test index still lists its LightLab test data as pending.
Relevant for: buyers comparing mode-selectable mid-size panel hardwareTradeoff: The physical and control specifications are well documented, but the current independent-test record explicitly says no LightLab test data are available yet.
Independent lab documentedRed light device
A compact eight-wavelength, mode-selectable MitoADAPT panel with a current primary manual path and a LightLab report for the tested MIN 4.0 sample.
Relevant for: buyers comparing mode-selectable spectral hardwareTradeoff: Its control and wavelength architecture is unusually configurable, but configuration breadth should not be confused with demonstrated clinical superiority.
Independent lab documentedRed light device
A 200-LED full-height Original 2.0 panel with current manufacturer specifications and manufacturer-hosted LightLab wall-draw, radiant-power and irradiance measurements.
Relevant for: larger two-wavelength panel comparisons with independent hardware dataTradeoff: The device has a useful independent hardware record, while its two-wavelength architecture is simpler than newer multi-band panels and does not by itself imply better or worse clinical performance.
Independent lab documentedRed light device
The widest Original 2.0 panel, with 300 LEDs, current manufacturer specifications and manufacturer-hosted LightLab measurements for wall draw, radiant power and six-inch irradiance.
Relevant for: large-area two-wavelength panel comparisonsTradeoff: The large format and third-party hardware measurements make the record technically useful, but size and output still need to be interpreted separately from clinical evidence and real-world fit.
Independent lab documentedRed light device
A 100-LED two-wavelength Original 2.0 panel with current manufacturer specifications and manufacturer-hosted LightLab measurements for the tested MitoMID 2.0 sample.
Relevant for: mid-size two-wavelength panel comparisonsTradeoff: The independent output record is detailed, but the current LightLab index and retail page disagree on panel height, so Homeapotherapy keeps the current retail dimension and flags the mismatch.
Independent lab documentedRed light device
A compact two-wavelength Original 2.0 panel with current manufacturer specifications and manufacturer-hosted LightLab measurements for the tested MitoMIN 2.0 sample.
Relevant for: compact panel comparisons with third-party radiometric dataTradeoff: The hardware record is unusually transparent for a legacy model, but the current product page contains a weight discrepancy that should be kept visible rather than normalized away.
Manufacturer documentedRed light device
A mid-size four-wavelength MitoPRO+ panel with current manufacturer specifications; Mito's independent-test index says its LightLab test is still in progress and replaces the former 750+ slot.
Relevant for: mid-size MitoPRO+ specification comparisonsTradeoff: The current physical and electrical specifications are clear, while the independent radiometric record remains explicitly incomplete.
Independent lab documentedRed light device
A larger four-wavelength MitoPRO+ panel with current manufacturer dimensions and electrical specifications plus LightLab radiometric measurements for the 1500+ v2 sample.
Relevant for: larger-panel comparisons using third-party output measurementsTradeoff: The independent report provides strong hardware transparency, while cross-brand clinical meaning still depends on exposure geometry, protocol and evidence outside the product spec sheet.
Desk researchedRed light device
A taller six-wavelength MitoPRO X panel with the same documented control model as the smaller X-series units and a 43-inch manual-listed panel height.
Relevant for: full-height panel specification comparisonsTradeoff: The current family manual is strong on operating and environmental parameters; independent optical performance remains a gap.
Independent lab documentedRed light device
A compact four-wavelength MitoPRO+ panel with current manufacturer specifications and a LightLab ISO/IEC 17025 hardware report for the tested 300+ v2 sample.
Relevant for: targeted panel comparisons with third-party radiometric dataTradeoff: Independent output data is unusually detailed, but it remains hardware testing of a submitted sample rather than a clinical comparison or Homeapotherapy measurement.
Desk researchedRed light device
A compact six-wavelength panel with Bluetooth/app controls. Homeapotherapy has verified the current manufacturer manual but has not independently measured optical or electrical performance.
Relevant for: compact targeted-use formatTradeoff: The documentation is relatively detailed, but performance figures remain manufacturer-supplied unless separately verified.
Desk researchedRed light device
A six-wavelength mid-size MitoPRO X panel documented in the January 2026 family manual, with app/remote controls and a larger footprint than the 300X.
Relevant for: mid-size panel specification comparisonsTradeoff: The primary manual is detailed, but normalized optical-output evidence remains manufacturer-supplied.
Desk researchedAntifungal care
A miconazole nitrate 2% vaginal antifungal cream labeled as a seven-night treatment for vaginal yeast infection, with explicit first-episode and recurrent-symptom warnings.
- Active
- Miconazole nitrate · 2%
- Vehicle
- Vaginal cream with disposable applicators
Relevant for: comparing seven-day OTC vaginal azole regimensTradeoff: The longer seven-day regimen uses a lower-concentration miconazole cream and has a distinct body-site label; it should not be compared as though it were interchangeable with external skin antifungal creams.
Product trial mixed resultsPrebiotic
One of the rare resistant-starch supplements with randomized trials using the named product itself. MSPrebiotic is potato-derived RS2; the pivotal trials used 30 g/day, increasing Bifidobacterium in both middle-aged and older adults and improving some glucose/insulin measures only in the older subgroup—not in middle-aged adults.
Relevant for: People specifically researching potato RS2 with product-specific randomized dataTradeoff: The exact product has randomized trial data, but the studied 30 g/day intake is large and metabolic benefits were subgroup-specific rather than universal.
Third party quality documentedOmega 3 dha
A pregnancy-focused DHA product with lot-specific certificate-of-analysis access, third-party purity/freshness testing and sustainable-fishing certification; these quality controls do not by themselves prove the finished product improves pregnancy outcomes.
Relevant for: Pregnant people whose diet/care plan calls for supplemental DHATradeoff: Strong purity, freshness and traceability signals, but it is a DHA product rather than a complete prenatal and finished-product outcome evidence is limited.
Evidence mappedImmune support
A useful anti-confusion comparator rather than a conventional prebiotic powder: two capsules provide 500 mg yeast beta-1,3/1,6-glucan plus 400 mg larch arabinogalactan. Those structures and doses are fundamentally different from 3 g oat beta-glucan or 15 g ResistAid microbiome studies, so the word beta-glucan must not collapse them into one evidence bucket.
Relevant for: Shoppers trying to understand yeast beta-glucan versus cereal beta-glucanTradeoff: Clear label and useful structural comparator, but its immune-oriented sub-gram ingredients should not borrow the clinical story of cereal beta-glucan or high-dose larch-fiber trials.
Evidence mappedPrebiotic
A high-dose single-ingredient digestion-resistant maltodextrin powder providing 12 g Fibersol-2 and 11 g soluble fiber per serving. Human trials have examined the same branded ingredient at 5-15 g doses for satiety, microbiota and stool/transit endpoints, giving this product a stronger ingredient-to-retail bridge than generic proprietary fiber blends.
Relevant for: Adults comparing a low-viscosity soluble fiber with human Fibersol-2 dataTradeoff: Strong branded-ingredient traceability and multi-endpoint human data, but a 12 g serving is a substantial fiber dose and clinical benefits remain endpoint-specific.
Evidence mappedPrebiotic
A straightforward 5 g short-chain FOS powder with no other ingredients. The serving exactly matches one dose in human scFOS dose-response work that increased fecal bifidobacteria, although the largest bifidogenic response in that trial occurred at 10 g/day. FOS remains highly fermentable and can aggravate bloating in sensitive users.
Relevant for: Adults specifically comparing short-chain FOS at a human-studied gram doseTradeoff: The 5 g serving matches a dose used in human scFOS research, but FOS is highly fermentable and the clearest evidence concerns microbiota changes rather than disease outcomes.
Evidence mappedPrebiotic
A single-ingredient USDA Organic acacia gum powder providing 6.5 g acacia gum and 6 g soluble fiber per tablespoon. A 2024 randomized IBS-C trial used 10 g/day acacia fiber and significantly improved stool frequency versus placebo, while not significantly improving stool consistency, stool mass or quality of life.
Relevant for: Adults comparing acacia gum as a gradually titratable soluble fiberTradeoff: Simple formula and useful randomized constipation data, but the trial dose was higher than one NOW serving and improvements were selective rather than global.
Evidence mappedPrebiotic
A unusually clean dose-to-ingredient-evidence match for an XOS prebiotic: the current NOW label supplies 2.2 g xylooligosaccharides from PreticX per teaspoon, within the low-gram range used in human XOS trials that increased fecal Bifidobacterium. The evidence supports a microbiota effect more clearly than symptom relief or metabolic treatment.
Relevant for: Adults comparing a low-gram XOS prebiotic with a clearly disclosed doseTradeoff: The 2.2 g XOS dose maps reasonably well to human microbiota trials and is easy to audit, but most of the evidence concerns bacterial composition rather than clinically important symptoms or disease outcomes.
Desk researchedAntifungal care
Prescription nystatin oral suspension indicated for candidiasis of the oral cavity; its minimal GI absorption makes it a local oral treatment rather than therapy for systemic candidiasis.
- Active
- Nystatin
- Vehicle
- Oral suspension
Relevant for: oral-thrush medicine comparisonsTradeoff: Repeated mouth dosing and local action versus systemic azole therapy.
Manufacturer documentedFoot care
A concentrated glycerin/allantoin foot cream with paraffin and dimethicone but no published urea or acid active; useful as a daily moisture-retention profile rather than a high-strength keratolytic.
- Urea
- Not listed / not established
- Vehicle
- Cream
Relevant for: daily moisture support for very dry intact feetTradeoff: A comparatively simple moisture-retention formula, but not directly comparable to high-urea or acid-based callus products.
Manufacturer documentedFoot care
A dedicated rough-foot cream built around alpha hydroxy acid, urea and shea butter. The cited manufacturer page identifies the ingredient classes but does not publish comparable percentages.
- Urea
- Present; concentration not stated on cited page
- Vehicle
- Cream
Relevant for: intact thick or callused heel skin where chemical exfoliation is desiredTradeoff: Combines two keratolytic classes with emollient support, but strength cannot be compared precisely without published concentrations.
Manufacturer documentedFoot care
An overnight moisture-focused foot cream built around glycerin, dimethicone, shea butter, panthenol and beeswax rather than a published high-strength keratolytic.
- Urea
- Not listed / not established
- Vehicle
- Night cream
Relevant for: nighttime moisture support for very dry intact feetTradeoff: Strong overnight barrier and emollient profile, but not directly comparable to high-strength urea/AHA callus formulas.
Desk researchedLaundry water system
A compact on-demand aqueous-ozone laundry system (LM201) with a published EPA establishment number, 12 V DC adapter and one-year warranty.
Relevant for: See fact sheetTradeoff: The current product page/manual do not publish a directly comparable ppm ozone concentration, water-pressure range or wattage figure; those omissions are shown explicitly rather than filled from another model.
Desk researchedLaundry water system
The +PLUS model (LM301) adds selectable Normal, Boost and No O3 modes to O3Waterworks' aqueous-ozone laundry platform, with explicit 0.5 and 1.0 ppm mode specifications.
Relevant for: See fact sheetTradeoff: Published ozone concentrations are manufacturer operating specifications; inlet-pressure range and wattage are not published in the cited page/manual, and Homeapotherapy has not independently measured cleaning outcomes.
Evidence mappedPrebiotic
An 11 g scoop supplies 3 g oat beta-1,3/1,4-glucan. Human outcome evidence for this dose range is strongest for LDL and total-cholesterol lowering, not for broad microbiome or immune claims.
Relevant for: Adults comparing an oat beta-glucan product at the dose used in cholesterol meta-analysesTradeoff: The 3 g serving aligns with the dose range used in cholesterol trials; microbiome evidence is secondary, and whole-oat studies do not establish every claim for an isolated product.
Manufacturer documentedFoot care
A solid heel-repair stick built around cocoa butter, shea butter and peppermint oil. Its main decision advantage is mess-free targeted application, not documented keratolytic strength.
- Urea
- Not listed / not established
- Vehicle
- Solid balm stick
Relevant for: targeted application to dry intact heelsTradeoff: Convenient stick format and occlusive/emollient profile, but no published urea/AHA/salicylic-acid active for direct keratolytic comparison.
Desk researchedEssential oil
A straightforward Lavandula angustifolia bottle with publicly described GC/MS testing practices; choose it for transparency, not because the brand’s wellness copy proves a health outcome.
Relevant for: buyers who want batch-test transparencyTradeoff: Strong lab-transparency story, but manufacturer wellness claims are not the same thing as clinical evidence.
Desk researchedEssential oil
A Mentha × piperita bottle with published batch GC/MS reports; its crisp sensory profile is easy to understand, while specific clinical findings about peppermint formulations should not be stretched into blanket diffuser claims.
Relevant for: buyers prioritizing botanical identity and test-report accessTradeoff: Good transparency, but route and formulation matter enormously when interpreting peppermint evidence.
Desk researchedRed light device
A larger 150-LED panel with seven manufacturer-published wavelength bands and independent LightLab reports for a tested BIOMAX 450 sample. Those reports verify specific laboratory measurements, not clinical efficacy.
Relevant for: larger-panel specification comparisonsTradeoff: Its documentation surface is richer than many panels, but sample-specific lab measurements should not be generalized beyond their stated test conditions.
Third party quality documentedMultivitamin
The company publishes supplier-level traceability and third-party quality testing, and the label lists 330 mg algal DHA. No product-specific clinical-outcome trial was identified in this review.
Relevant for: Men 18–49 prioritizing visible ingredient sourcingTradeoff: Strong traceability and concise dosing versus narrower nutrient breadth and limited product-specific efficacy evidence.
Third party quality documentedMultivitamin
A traceable iron-free men’s 50+ formula with 16 mcg B12 and 330 mg DHA; its quality documentation is stronger than its product-specific outcomes evidence.
Relevant for: Men 50+ who value supplier-level traceabilityTradeoff: Strong traceability and age-stage design, but no product-specific clinical-outcome trial identified.
Product trial plus qualityMultivitamin
Ritual discloses supplier-level traceability, is USP Verified, and has a product-specific placebo-controlled trial showing higher vitamin D and DHA biomarkers. The trial does not establish broad disease prevention or symptom benefit.
Relevant for: Adults 18–49 who want supplier-level traceabilityTradeoff: The company publishes supplier-level traceability and quality documentation; the formula covers a selected set of nutrients, and its product-specific trial measured biomarkers rather than clinical outcomes.
Third party quality documentedMultivitamin
A traceable post-menopause formula with higher B12 and no listed iron, consistent with common 50+ formulation logic; no product-specific outcome trial was identified.
Relevant for: Women 50+ prioritizing traceability and an iron-free formulaTradeoff: Good age-stage formulation logic and sourcing transparency, but broad 50+ outcome evidence cannot be assumed from other multivitamin products.
Manufacturer documentedPrenatal postnatal
The label includes DHA plus folate, iron, iodine and choline, and the company publishes supplier-level traceability. Its 55 mg choline and 150 mcg iodine do not by themselves meet pregnancy Daily Values, so adequacy depends on the full diet and care plan.
Relevant for: People planning pregnancy or pregnant who value vegan DHA and supplier-level traceabilityTradeoff: Supplier-level traceability and DHA content are documented, but no qualifying product-specific clinical-outcome trial was identified and the listed choline and iodine amounts do not cover pregnancy Daily Values by themselves.
Ingredient strain evidencePrebiotic synbiotic
The label names LGG and BB-12, PreforPro and tributyrin and publishes supplier-level traceability. Evidence for individual components is stronger than evidence for the finished multi-component product on clinical outcomes.
Relevant for: People comparing synbiotics by named strains and defined prebiotic ingredientsTradeoff: The component identities and sourcing are well documented, but the multi-component formula makes finished-product effects difficult to attribute without product-specific trials.
Evidence mappedPrebiotic
A particularly useful prebiotic comparator because one serving supplies 6 g of PHGG—the same daily PHGG amount used in a placebo-controlled IBS trial that improved bloating and bloating-plus-gas but did not improve overall IBS severity or quality-of-life scores. It is also Monash Low FODMAP certified according to the manufacturer.
Relevant for: People who want a measurable prebiotic fiber dose rather than a token amount inside a capsule blendTradeoff: Strong dose-to-trial match for PHGG and good label simplicity; evidence supports specific outcomes, not a cure-all microbiome claim.
Evidence mappedProbiotic
A purpose-built antibiotic-period formula with 10 billion CFU from S. boulardii plus three bacterial species. Despite the name, the exact strains are not disclosed, and the blend is not the same formulation described in AGA's strain/formulation-specific guidance.
Relevant for: People whose clinician specifically selected this product during antibiotic treatmentTradeoff: Convenient antibiotic-focused positioning, but the evidence bridge from guideline-supported strains to this exact blend is incomplete.
Evidence mappedProbiotic
The current US page lists 25 billion CFU across 12 species and recommends refrigeration. It does not show strain designations, which limits the ability to map strain-specific trial results to the blend.
Relevant for: People already using this formula with a clinician who values its broad species mix and allergen profileTradeoff: The label gives species-level quantities but not strain designations on the current US page, limiting strain-specific trial matching.
Evidence mappedProbiotic
A simple 3-billion-CFU S. boulardii capsule from the Klaire Labs/Ther-Biotic line. The important limitation is that SFI does not identify a strain on the current page, so evidence for CNCM I-745 or another named S. boulardii strain should not be treated as proof for this product.
Relevant for: People whose clinician specifically wants this Klaire/SFI product and understands the species-versus-strain limitationTradeoff: Simple formula and clear CFU amount, but much weaker trial traceability than a strain-identified S. boulardii product.
Evidence mappedSynbiotic
The strongest current Ther-Biotic product for transparency: it provides 50 billion CFU, identifies most organisms to strain level, and uses low-FODMAP-certified PHGG (Sunfiber). The catch is dose: only 200 mg PHGG is listed, far below the 6 g/day used in a placebo-controlled PHGG trial that improved bloating but not overall IBS severity.
Relevant for: People who want a practitioner-oriented multi-strain formula with much better strain disclosure than Ther-Biotic CompleteTradeoff: Good label engineering and strain transparency; the prebiotic amount is too small to borrow the strongest PHGG symptom data.
Desk researchedAntifungal care
A tolnaftate 1% powder spray with a jock-itch-specific label and a two-week treatment course.
- Active
- Tolnaftate · 1%
- Vehicle
- Aerosol powder spray
Relevant for: jock-itch-specific powder-spray comparisonsTradeoff: The active matches other tolnaftate products, but the labeled indication and course are formulation/SKU specific, reinforcing why brand-level comparisons are not enough.
Desk researchedAntifungal care
A tolnaftate 1% cream labeled to treat most athlete's foot and ringworm and to help prevent most athlete's foot with daily use.
- Active
- Tolnaftate · 1%
- Vehicle
- Cream
Relevant for: tolnaftate 1% comparisonsTradeoff: The current cited cream label includes athlete's-foot prevention language, but its listed treatment indications are narrower than some multi-condition azole or terbinafine creams.
Desk researchedAntifungal care
A tolnaftate 1% dry powder spray labeled to treat most athlete's foot and ringworm and help prevent most athlete's foot with daily use.
- Active
- Tolnaftate · 1%
- Vehicle
- Aerosol powder spray
Relevant for: dry powder-spray applicationTradeoff: The dry aerosol is convenient for feet and footwear-adjacent routines but introduces flammability and inhalation-misuse warnings.
Desk researchedWater ionizer
Tyent's current ACE page presents a configurable countertop ionizer: the Hydrogen Boost option moves the platform from 11 to 13 plates and publishes a 1.7–12.5 pH range and ORP down to about -1150 mV.
Relevant for: See fact sheetTradeoff: The current Tyent page has changed from older standalone ACE-13 documentation. Homeapotherapy now uses the live product page rather than a legacy direct PDF that no longer resolves reliably, and it leaves unpublished physical/flow fields explicit instead of carrying stale values forward.
Desk researchedEczema care
Lightweight non-drug moisturizer with glycerin, sodium hyaluronate and five named ceramides; fragrance-free and barrier-focused.
- Active
- None — cosmetic moisturizer/barrier care · Not applicable
- Vehicle
- Moisturizer
Relevant for: five-ceramide formula comparisonsTradeoff: Ceramide variety is a formula fact, not a dose or efficacy score.
Desk researchedEczema care
Fragrance-free barrier moisturizer with petrolatum and a short published ingredient list; normalized as non-drug moisturizer care.
- Active
- None — cosmetic moisturizer/barrier care · Not applicable
- Vehicle
- Cream
Relevant for: petrolatum-containing cream comparisonsTradeoff: Simple barrier care is a different product job from an OTC anti-itch active.
Desk researchedFoot care
A single-ingredient 100% white petrolatum skin protectant. It provides a clean occlusive comparison point against multi-ingredient urea and acid heel products.
- Urea
- Not listed / not established
- Vehicle
- Petroleum jelly / skin protectant
Relevant for: single-ingredient occlusive comparisonsTradeoff: The formula is simple and highly occlusive, but it does not contain the exfoliating ingredients found in dedicated rough-skin heel creams.
Manufacturer documentedFoot care
A simple petrolatum/lanolin/paraffin balm with no added fragrance and no keratolytic acid or urea. It fits the occlusive-barrier side of heel care rather than callus exfoliation.
- Urea
- Not listed / not established
- Vehicle
- Balm
Relevant for: very dry intact heels needing a heavy occlusive balmTradeoff: Strongly occlusive and simple, but does not provide the keratolytic action of urea/AHA/salicylic-acid formulas.
Evidence mappedProbiotic medical food
Visbiome identifies the eight strains in the De Simone Formulation, and AGA pouchitis guidance notes that this formulation was used in recurrence-prevention trials. That evidence is specific to pouchitis and should not be generalized to IBS or other GI complaints.
Relevant for: People with recurrent antibiotic-responsive pouchitis discussing prevention with their gastroenterologistTradeoff: Formulation identity and pouchitis-guideline relevance are documented; refrigeration, high potency and the narrow medical-use evidence make it unsuitable as a generic wellness default.
Desk researchedAir purifier
Vollara's standard Pro pairs two ActivePure cell assemblies with an activated-carbon filter and HEPA filter screen in a compact room unit.
Relevant for: See fact sheetTradeoff: Its manual gives fan airflow and a manufacturer coverage estimate rather than AHAM CADR, so those values should not be treated as directly equivalent to purifier CADR ratings.
Desk researchedAir purifier
Vollara's larger room unit combines two ActivePure cells with a HEPA filter screen, activated carbon and optional ionization; its coverage figure is a manufacturer diffusion claim, not an AHAM CADR rating.
Relevant for: See fact sheetTradeoff: Detailed manual specifications are available, but Homeapotherapy has not independently measured air-cleaning performance and the stated coverage basis is not directly comparable with AHAM CADR/ACH ratings.
Desk researchedAir purifier
The Pro+ adds a purification plate and a high-ozone Depart Room Mode to a PCO-A/filtration platform; Vollara's manual restricts that mode to unoccupied spaces.
Relevant for: See fact sheetTradeoff: This model requires unusually careful mode-specific safety reading: its manual says it does not meet California requirements, cannot be shipped to California or Canada, and the Depart Room Mode is for unoccupied areas only.
Desk researchedAir purifier
A small rechargeable ActivePure unit documented for close-range/personal-space use, with an eight-hour listed battery runtime and manufacturer coverage up to 50 square feet for one occupant.
Relevant for: See fact sheetTradeoff: It is not a conventional high-throughput HEPA room purifier, so its 50-square-foot use statement should not be compared directly with AHAM CADR room-size ratings.
Desk researchedHydrogen water device
A 400 mL portable hydrogen-water device using a manufacturer-described SPE membrane and platinum-coated titanium plate, with a published hydrogen concentration range up to 1,100 ppb.
Relevant for: See fact sheetTradeoff: Hydrogen concentration and ORP are manufacturer device specifications; this page does not infer disease-treatment benefit from them.
Desk researchedLaundry water system
A cold-water laundry appliance still listed in Vollara's manuals library, using an ActivePure-based water-treatment system and very low published operating power.
Relevant for: See fact sheetTradeoff: Vollara's current storefront points to a newer Laundry Pro 3.0 line while its manuals library still exposes LaundryPure 2.0 documentation; this record is deliberately scoped to the 2.0 model rather than blending generations.
Desk researchedWater ionizer
A countertop water ionizer using Direct Disk Ionization with two prefilters; Vollara publishes broad pH and ORP ranges that depend on source-water conditions.
Relevant for: See fact sheetTradeoff: Published pH, ORP and chlorine-removal values are manufacturer specifications, not evidence that alkaline or low-ORP water treats disease.
Desk researchedAntifungal care
A miconazole nitrate 2% liquid aerosol spray labeled for most athlete's foot, ringworm and jock itch, with aerosol flammability and pressure warnings.
- Active
- Miconazole nitrate · 2%
- Vehicle
- Liquid aerosol spray
Relevant for: comparing liquid spray delivery with creams and powder spraysTradeoff: The spray format avoids rubbing in a cream but adds flammability, pressurized-container and inhalation-misuse warnings.